A concerned parent is holding the NHS accountable for their child’s severe disability due to the lack of testing for a muscle wasting disease at birth, citing significant delays in the process. The Mirror has initiated a campaign advocating for the inclusion of spinal muscular atrophy (SMA) in the NHS newborn heel prick test, a step already taken by most developed countries. Ollie Williams, a five-year-old who faced a three-month delay in receiving his SMA diagnosis after birth, now relies on constant support for basic functions like breathing, eating, and sitting.
Ollie’s parents, Ben and Amy, are determined to prevent similar tragedies in other British children, where an estimated 33 babies each year end up in wheelchairs due to the absence of newborn screenings. While Scotland is set to implement nationwide SMA screening in the near future, the UK National Screening Committee has postponed the rollout of the £5 blood test on the NHS, opting for a limited pilot in select regions of England and Wales.
Ben criticized the committee for prioritizing data collection over timely decision-making, resulting in avoidable disabilities and fatalities, as seen in the delayed diagnosis of Jesy Nelson’s twins. The article also highlights the personal experiences of Ollie, who, like Jesy’s twins, suffers from Type 1 SMA, requiring extensive medical support and specialized equipment for daily living. Despite being carriers of SMA, a screening revealed that Ollie’s younger sister, Hailey, was unaffected, emphasizing the importance of early detection.
The ongoing campaign by The Mirror underscores the urgency of addressing the deficiency in the NHS newborn screening program, which fails to detect SMA while other countries have successfully integrated it into their protocols. Novartis estimates that 33 infants in the UK annually face permanent disability due to delayed diagnosis. The UK lags behind in newborn SMA screening compared to other nations, despite the availability of advanced treatments that could significantly mitigate the condition’s impact if administered promptly.
The article concludes with statements from Ben urging immediate action to implement SMA screening for all newborns, stressing the practicality, effectiveness, and cost-efficiency of such measures. The Department of Health and Social Care expressed sympathy for affected families and emphasized the importance of ongoing research and trials to enhance early detection and treatment of SMA.